Search for: "K-V Pharmaceutical Company"
Results 101 - 120
of 221
Sort by Relevance
|
Sort by Date
29 Jul 2013, 7:45 am
In In re Rigel Pharmaceuticals, Inc. [read post]
5 Jul 2013, 5:00 am
Mutual Pharmaceutical Co., 760 F. [read post]
28 Jun 2013, 6:01 pm
” (R. v. [read post]
21 Jun 2013, 6:43 pm
In Burton v. [read post]
20 Jun 2013, 10:04 am
FTC v. [read post]
6 Jun 2013, 12:15 am
The doctrine of inherent anticipation (particularly after Schering Co. v Geneva Pharmaceuticals Inc. et Al., commented here - see also, in the UK, Merrell Dow v H N Norton & Co), may lead to similar distortions. [read post]
7 May 2013, 8:24 am
The overzealous war against Internet pharmaceuticals has already taken a half-billion dollar toll on Google and another $40M toll on UPS (yes, the shipping company). [read post]
30 Apr 2013, 12:14 pm
Bristol-Myers Squibb Company, 2013 U.S. [read post]
7 Apr 2013, 7:26 pm
Lee (Kenyon & Kenyon) noted that both brand-name pharmaceutical companies and generics want reverse payments to continue. [read post]
5 Apr 2013, 1:01 pm
Solo v. [read post]
26 Mar 2013, 5:17 pm
Yu was Assistant General Counsel, Litigation for Affymetrix, Inc., the first company to commercialize DNA microarrays.Federal Trade Commission v. [read post]
24 Mar 2013, 9:56 pm
Watson), in which the Court will decide when a brand-name pharmaceutical company may offer a "reverse payment" settlement to a generic company in exchange for the generic dropping a patent challenge and staying out of the market. [read post]
3 Mar 2013, 12:06 pm
Granted Anoop K Joy 1251/KOL/2006 OTSUKA PHARMACEUTICAL CO. [read post]
1 Mar 2013, 2:30 pm
All the while Maya v. [read post]
7 Jan 2013, 12:12 pm
That left the claims against the pharmaceutical companies. [read post]
14 Nov 2012, 5:00 am
By Bob Rouder and Saul PerloffIn February, 2011, K-V Pharmaceuticals received FDA approval to market its branded pregnancy drug, Makena® as an orphan drug. [read post]
9 Nov 2012, 10:07 am
K-V Pharmaceutical Company ("K-V") has taken the fight over its preterm-birth prevention drug, Makena® (17-hydroxypreogesterone caproate solution) ("HPC"), to the International Trade Commission ("ITC"). [read post]
24 Oct 2012, 3:51 pm
On October 23, 2012, K-V Pharmaceutical Company of St. [read post]
23 Oct 2012, 6:30 am
Professional Drug Co. v. [read post]
